Akili, Inc.$0.43 %
Analyst Rating: Hold
Stock Details
CEO
Matthew Franklin
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Full Time Employees
68
Address
125 Broad Street, Boston, MA, 02110
Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.
Top Competitors
Income Statement
Financials
Selected Year
Revenue Estimates
EPS Estimates
Net Income Estimates
Price target for Akili, Inc. $0.43
$0
Min Forecast(+0% )
$249.61
Avg Forecast( +0% )
$325
Max Forecast(+0%)
EPS
Revenue
Institutional Holder
Loading institutional holder data...
Congress Tracker
Showing 0 of 0 results
Insider Trading of Key Employees
Showing 0 of 0 results